Last year, DL News attempted to predict the top three DeFi trends for 2025. We forecast that traditional finance would enter DeFi at an unprecedented pace, more protocols would launch their own blockchains, and financial technology firms would incorporate DeFi into their offerings at scale. Well, we did quite well. In 2025, we saw banks launch stablecoins, asset managers allocate billions of dollars to DeFi lenders, and Wall Street firms pile into tokenised assets. In January, Coinbase kicked off the ...

Best Buy Canada has an awesome Boxing Day Sale available now. Enjoy great savings on many brands and a low price guarantee. Save on all Logitech, Beats, Bose products and much more.Best Buy Canada has FREE shipping on orders of $35 or more. Here are some of the markdowns that are part of the Boxing Day Sale: Save $800 on Samsung 65″ S84F Series 4K UHD HDR OLED Tizen Smart TVSave $130 on PlayStation 5 Pro ConsoleGet the Nintendo Switch 2 Mario Kart World Bundle for $699.99Save $126 on Sony WH-CH720N Over-Ear ...

BANGKOK (AP) — Asian shares were mixed Thursday in thin holiday trading, with most markets in the region and elsewhere closed for Christmas. In Tokyo, the Nikkei 225 edged 0.1% higher to 50,407.79. It has gained nearly 30% this year. The dollar slipped to 155.85 Japanese yen from 155.94 yen. The euro climbed to $1.1786 from $1.1780. Markets in mainland China advanced, with the Shanghai Composite index up 0.5% at 3,959.62. Hong Kong's exchange was closed. Investors were encouraged by a statement by the ...

Group 1: Acquisition Details - Sanofi will commence a cash tender offer to acquire all outstanding shares of Dynavax Technologies at $15.50 per share, representing approximately $2.2 billion in total equity value [2] - The offer price reflects a 39% premium over Dynavax's closing price on December 23 and a 46% premium over its three-month volume-weighted average price as of December 23 [2] - The Dynavax board has unanimously approved the transaction [4] Group 2: Product and Pipeline - The acquisition includes HEPLISAV-B, an adult hepatitis B vaccine available in the U.S., which is administered in two doses over one month, unlike the traditional three-dose schedule [3] - Sanofi's Executive Vice President of vaccines stated that Dynavax enhances Sanofi's adult immunization presence by adding differentiated vaccines [3] Group 3: Regulatory and Financial Aspects - The acquisition is subject to regulatory approvals, including antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act, and other customary conditions [5] - Sanofi intends to fund the acquisition with available cash [6] - Dynavax was advised by Centerview Partners LLC and Goldman Sachs & Co. LLC during the transaction [6] Group 4: Stock Performance - Shares of Dynavax surged 38.19% in regular trading on Wednesday, closing at $15.38, before slightly tapering to $15.37 in after-hours trading [1] - The stock has a market capitalization of $1.81 billion and has gained 18.04% over the past 12 months and 55.98% over the last six months [7] - Currently, the stock is trading at 98.3% of its 52-week range, indicating it is near its highs, which reinforces bullish sentiment [8]

Welcome to Motley Fool Money. I'm your host Emily Flippen. Today, I'm joined by Fool analysts Jason Hall and Sanmeet Dao to discuss the IPO market. We'll be taking a look back at what reopened the IPO window over the course of the past year, run the biggest IPOs of 2025 through a rule Breakers lens, and make a few predictions for the 2026 IPO markets, including discussing if it really never makes sense to buy into an IPO. Now, the IPO market in 2025 was obviously much hotter than 2024. The third quarter of ...

Crypto Retail Investors. Photo by BeInCrypto Retail participation in the cryptocurrency market has continued to decline throughout this cycle, with interest weakening further as the year draws to a close. While some analysts still interpret fading retail engagement as a classic bottom signal, others argue the current downturn reflects a deeper cultural and social shift, where investor attention has moved away from crypto altogether. Does Retail Apathy Mark a Bottom or a New Phase? The crypto market’s ...

Core Viewpoint - The optimistic outlook on Immatics (IMTX) is based on the successful execution of the company's three-wave strategy aimed at commercializing its products [1] Group 1: Company Strategy - The first wave of the strategy focuses on establishing a systematic approach to product commercialization [1] Group 2: Investment Perspective - There is a strong inclination towards investing in high-growth companies, particularly in sectors expected to experience exponential growth [1] - The analysis emphasizes the importance of understanding and investing in disruptive technologies and innovative enterprises [1] - The investment approach combines fundamental analysis with predictions of future trends, highlighting the potential for substantial returns through innovation [1]

Core Viewpoint - The optimistic outlook on Immatics (IMTX) is based on the successful execution of the company's three-wave strategy for product commercialization [1] Group 1: Company Strategy - The first wave of the strategy focuses on establishing a systematic approach to commercializing the company's products [1] Group 2: Investment Philosophy - There is a strong inclination towards investing in high-growth companies, particularly in sectors expected to experience exponential expansion [1] - The investment approach combines fundamental analysis with predictions of future trends, emphasizing the potential of innovation to generate substantial returns [1]

Core Viewpoint - StoneCo Ltd. (STNE) stock has gained approximately 10% since last July, aligning with the performance of the S&P 500, but it has not yet reached the anticipated target of $30 [1]. Company Analysis - The stock performance of StoneCo has been steady, reflecting broader market trends, but it remains below the target price set previously [1]. - The company is under the coverage of an experienced equity analyst with over 10 years in the investment industry, indicating a level of expertise in the analysis of its stock [1]. Analyst Background - The analyst has a significant following and has contributed to various investment platforms, showcasing a strong reputation in the field [1]. - The analyst is a CFA Level III candidate and holds qualifications from the Chartered Institute for Securities and Investment (CISI), adding credibility to the analysis [1].

Core Viewpoint - StoneCo Ltd. (STNE) stock has gained approximately 10% since last July, aligning with the performance of the S&P 500, but it has not yet reached the anticipated target of $30 [1]. Company Summary - StoneCo Ltd. is currently experiencing a stock price increase, but it remains below the target price set previously [1]. - The company is under analysis by an experienced equity analyst with over 10 years in the investment industry, focusing on small-cap stocks often overlooked by Wall Street [1]. Analyst Background - The analyst has qualifications from the Chartered Institute for Securities and Investment (CISI) and is a CFA Level III candidate, indicating a strong background in investment analysis [1]. - The analyst has contributed to various investment platforms, showcasing a significant following and expertise in equity research [1].